Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant

(2022) Nick Andrews et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of the coronavirus disease 2019 epidemic and a free influenza vaccine strategy on the willingness of residents to receive influenza vaccines in Shanghai, China

(2021) Yehong Zhou et al.   Human Vaccines & Immunotherapeutics

Heightened Willingness toward Pneumococcal Vaccination in the Elderly Population in Shenzhen, China: A Cross-Sectional Study during the COVID-19 Pandemic

(2021) Minyi Zhang et al.   Vaccines

Cost-effectiveness of dual influenza and pneumococcal vaccination among the elderly in Shenzhen, China

(2021) Daqin Chen et al.   VACCINE

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults

(2021) Nawal Al Kaabi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Changes in the pathogenic spectrum of acute respiratory tract infections during the COVID-19 epidemic in Beijing, China: A large-scale active surveillance study

(2021) Mei Dong et al.   JOURNAL OF INFECTION

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

(2021) Jamie Lopez Bernal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunogenicity and safety levels of inactivated quadrivalent influenza vaccine in healthy adults via meta-analysis

(2021) Yu Liang et al.   Human Vaccines & Immunotherapeutics

Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years — COVID-NET, 13 States, February–April 2021

(2021) Heidi L. Moline et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Vaccination coverage with the pneumococcal and influenza vaccine among persons with chronic diseases in Shanghai, China, 2017

(2020) Yuheng Wang et al.   BMC PUBLIC HEALTH

An outbreak of acute respiratory infection at a training base in Beijing, China due to human adenovirus type B55

(2020) Guilan Lu et al.   BMC INFECTIOUS DISEASES

Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality

(2020) Deus Thindwa et al.   VACCINE

Vaccination pattern of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Hangzhou, China: a coverage and adverse events following immunization of different age groups

(2020) Yan Liu et al.   Human Vaccines & Immunotherapeutics

Pneumococcal vaccine coverage among individuals aged 18 to 64 years old with underlying medical conditions in the UK: a retrospective database analysis

(2020) Ian Matthews et al.   BMC PUBLIC HEALTH

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

(2020) Shengli Xia et al.   LANCET INFECTIOUS DISEASES

Decreased Influenza Activity During the COVID-19 Pandemic — United States, Australia, Chile, and South Africa, 2020

(2020) Sonja J. Olsen et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults

(2019) Brandon Essink et al.   VACCINE

Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals: A randomized, open-label, non-inferiority trial

(2018) Kei Nakashima et al.   Human Vaccines & Immunotherapeutics

Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15

(2018) Brian Wahl et al.   Lancet Global Health

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50 years of age: Results from a phase III, randomized, non-inferiority trial

(2017) Opokua Ofori-Anyinam et al.   VACCINE

Seasonal influenza vaccination in China: Landscape of diverse regional reimbursement policy, and budget impact analysis

(2016) Juan Yang et al.   VACCINE

The free vaccination policy of influenza in Beijing, China: The vaccine coverage and its associated factors

(2016) Min Lv et al.   VACCINE

Vaccine hesitancy: Definition, scope and determinants

(2015) Noni E. MacDonald   VACCINE

Benefits and Effectiveness of Administering Pneumococcal Polysaccharide Vaccine With Seasonal Influenza Vaccine: An Approach for Policymakers

(2012) Shawn A. N. Gilchrist et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Prevention of Acute Myocardial Infarction and Stroke among Elderly Persons by Dual Pneumococcal and Influenza Vaccination: A Prospective Cohort Study

(2010) Ivan F. N. Hung et al.   CLINICAL INFECTIOUS DISEASES